Supply Constraint of Sarilumab [Kevzara®]
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Kevzara
|
| Active substance |
sarilumab
|
| Therapeutic area (MeSH) |
Arthritis, Rheumatoid
|
| Regulatory outcome |
Variation
|
| DHPC type |
Medicine shortage
|
| Human ATC code |
L04AC14
|
| Dissemination date |
09/11/2021
|